HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Anthony Caggiano M.D., Ph.D., Senior Director, Preclinical Development, will present an overview of the Company’s preclinical pipeline at the Windhover Therapeutic Area Partnerships Conference on Tuesday, November 4, 2008 at 3:50 p.m. ET at the Loews Philadelphia Hotel in Philadelphia, PA.
